LAHCF | Health Care Fund | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Health Care Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Health Care Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of companies within the health care sector.

Fund Basicsas of 03/31/2022

Total Net Assets
$7.00 M
Inception Date
08/01/2019
Dividend Frequency
Monthly (Daily Accrual)
Fund Gross Expense Ratio
4.65%
Fund Net Expense Ratio
1.78%
Number of Holdings
69
Minimum Initial Investment
$1,500+

Fund Expense Ratio :

Gross 4.65%

Net 1.78%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge -15.08% -11.35% - - - 11.08%
Lipper Category Avg. Health/Biotechnology Funds -17.21% -13.64% - - - -
MSCI ACWI Health Care Index (Net) -8.37% 3.09% - - - 13.10%
w/ sales charge -15.93% -12.17% - - - 11.08%

Fund Expense Ratio :

Gross 4.65%

Net 1.78%

Fund Expense Ratio :

Gross 4.65%

Net 1.78%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge -7.90% 0.84% - - - 14.88%
Lipper Category Avg. Health/Biotechnology Funds -8.85% -1.79% - - - -
MSCI ACWI Health Care Index (Net) -3.79% 12.56% - - - 15.62%
w/ sales charge -8.82% -0.10% - - - 14.88%

Fund Expense Ratio :

Gross 4.65%

Net 1.78%

INVESTMENT TEAM

Devesh Karandikar
Devesh Karandikar

Portfolio Manager & Research Analyst

26 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

21 Years of Industry Experience

Heidi A. Lawrence
Heidi A. Lawrence

Portfolio Manager

20 Years of Industry Experience

Samantha E. Shevins
Samantha E. Shevins

Portfolio Manager

21 Years of Industry Experience

Supported By 19 Investment Professionals with 34 Years Avg. Industry Experience

Contact a Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 4.65%

Net 1.78%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge -15.08% -11.35% - - - 11.08%
Lipper Category Avg. Health/Biotechnology Funds -17.21% -13.64% - - - -
MSCI ACWI Health Care Index (Net) -8.37% 3.09% - - - 13.10%
w/ sales charge -15.93% -12.17% - - - 11.08%

Fund Expense Ratio :

Gross 4.65%

Net 1.78%

Fund Expense Ratio :

Gross 4.65%

Net 1.78%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge -7.90% 0.84% - - - 14.88%
Lipper Category Avg. Health/Biotechnology Funds -8.85% -1.79% - - - -
MSCI ACWI Health Care Index (Net) -3.79% 12.56% - - - 15.62%
w/ sales charge -8.82% -0.10% - - - 14.88%

Fund Expense Ratio :

Gross 4.65%

Net 1.78%

NAV Historical Prices

Date Net Asset Value

Portfolio

Portfolio

Portfolio Details as of 03/31/2022

Total Net Assets
$7.00 M
Number of Holdings
69
Weighted Average Market Cap.
125.2 B
P/B Ratio
6.6x
P/E Ratio
28.8x

Attribution Analysis 

Health Care Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Contributors & Detractors as of  03/31/2022

Contributors

Holding Contribution
AstraZeneca PLC 0.5%
Vertex Pharmaceutica 0.3%
Intra Cellular Therapie 0.2%
AmerisourceBergen Corp. 0.2%
Novo Nordisk A/S 0.1%

Detractors

Holding Contribution
Natera Inc -0.7%
Align Technology, Inc. -0.6%
Zoetis Inc -0.6%
Thermo Fisher Scientifi -0.5%
10x Genomics Inc -0.4%

Fees & Expenses

Fees & Expenses

Expense Ratioas of 04/30/2022

Fund Gross Expense Ratio Fund Net Expense Ratio
4.65% 1.78%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field